(1)
A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. AJPHS 2022, 12 (4), 2729-2738. https://doi.org/10.5530/ezagjy22.